Related Experiment Video
Updated: Jul 13, 2026
08:56
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
[Clinical development and future perspective of biological agents]
1Division of Rheumatology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 24, 2007
Summary
Biological agents targeting pro-inflammatory cytokines significantly impact inflammatory disorder treatments like rheumatoid arthritis. This review focuses on the clinical development and future of TNF inhibitors in Japan.
Area of Science:
- Immunology
- Pharmacology
Context:
- Inflammatory disorders, such as rheumatoid arthritis, pose significant therapeutic challenges.
- Biological agents targeting pro-inflammatory cytokines have emerged as a key treatment modality.
Purpose:
- To review the clinical development of biological agents in Japan.
- To specifically examine the progress of Tumor Necrosis Factor (TNF) inhibitors.
- To discuss future perspectives for these therapies.
Summary:
- Biological agents targeting pro-inflammatory cytokines have revolutionized inflammatory disease management.
- The paper reviews the clinical development of these agents in Japan, with a focus on TNF inhibitors.
- Future trends and potential advancements are also considered.
Impact:
- Provides a comprehensive overview of biological agent development in Japan.
- Highlights the role and future potential of TNF inhibitors in treating inflammatory conditions.
- Informs clinicians and researchers on the current landscape and future directions of biologic therapies.
More Related Videos
07:43A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
Published on: July 14, 2023
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
Related Concept Videos
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...